| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 40776 | Strategic Integrated Projects - Environment Expected Impact:Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Support the full implementation of the following plans and strategies:- Circular Economy: National or Regional Circular Economy Action Plans, Strategies, Roadmaps or similar, which are officially approved, and which include specific and measurable actions, or targets, with a clear timeline and are in line with or complement the objectives of the EU Circular Economy Action Plan and, w... |
||||||
| 40777 | Strategic Nature Projects Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy,... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Support the full implementation of the following plans and strategies:The Prioritised Action Frameworks (PAFs) pursuant to Article 8 of Council Directive 92/43/EEC on the conservation of natural habitats and of wild fauna and flora (the Habitats Directive) and;National restoration plans pursuant to Article 14 of Regulation (EU) 2024/1991 of the European Parliament and the Council on nature restorati... |
||||||
| 40778 | Strategic Integrated Projects - Climate Action Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy,... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Target the implementation of one or more of the following plans/strategies: Final updated National Energy and Climate Plans (NECP) and Long-Term Strategies (LTS) pursuant to Regulation on the governance of the energy union and climate action (EU) 2018/1999.National adaptation strategies and plans pursuant to Article 5 of the Regulation 2021/1119 (‘European Climate Law’), or regional adaptation strat... |
||||||
| 40779 | Portugal – Cleaning services – Aquisição de serviços de Limpeza e Higienização de Edificios Municipais Buyer: Município de Vale de Cambra | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-04 | Tender Procurement Contract | Portugal | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Município de Vale de Cambra | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-04 |
||||||
| 40780 | NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) This NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR, a re-issue of PAR-24-208, wa... | Grant Mixed | United States | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | Grants.gov |
|
Source description
This NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR, a re-issue of PAR-24-208, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V. Application Review Information of the funding opportunity are the only changes that have been made. All other aspects of this funding opportunity remain the same. |
||||||
| 40781 | Africa-EU CO-FUND action on climate Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:A long-term collaboration on... | Research Funding Cash Grant | Europe | Expected EU contribution: 15,000,000 EUR - 15,000,000 EUR | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:A long-term collaboration on climate change research between the EU and the African Union is established through development and implementation of the Climate Action pillar of the EU-AU Research and Innovation Partnership on Climate Change and Sustainable Energy (CCSE),[1] in co-design between African and European partners;Reduced fragmentation by aligning the EU, national and multilateral R&I efforts with increased leverage and impact of funding;African scientific, policy and practice communities have knowledge and tools to better understand, withstand and adapt to the accelerating effects of climate change, fostering science-based implementation of the Paris Agreement, the Sendai Framework for Disaster Risk Reduction, the Nairobi Declaration on Climate Change, the international dimensi... |
||||||
| 40782 | Assessing the performance of policy instruments to inform climate change mitigation action Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Enhanced knowledge of the ef... | Research Funding Cash Grant | Europe | Expected EU contribution: 3,000,000 EUR - 3,000,000 EUR | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Enhanced knowledge of the effectiveness of policy instruments on EU and Member State level to inform mitigation action and policy improvements, ensuring a fair transition and social acceptability;Methodologies are developed and improved for ex-ante assessment and ex-post evaluation of greenhouse gas emission reductions from climate policies and measures;Strengthened collaboration and established networks between researchers, policy experts and government officials involved in designing and evaluating climate policies on EU and national level. Scope:As the EU and its Member States intensify efforts to reduce their greenhouse gas (GHG) emissions to achieve climate neutrality by 2050, understanding the effectiveness and acceptability of policy instruments becomes crucial. The implementation... |
||||||
| 40783 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40784 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40785 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40786 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40787 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40788 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40789 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40790 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Fluticason, ATC R03AK11 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40791 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Meropenem, ATC J01DH02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40792 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Fluticasonfuroat, ATC R03AK10 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40793 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Aclidiniumbromid, ATC R03BB05 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40794 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40795 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ranibizumab in der Darreichungsform Injektionslösung in der Durchstechflasche, ATC S01LA04 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40796 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Dexamethason und Gentamicin, ATC S01CA21 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40797 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40798 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. z. intramuskulären Injektion), ATC L03AB07 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40799 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fertigarzneimittel SMOFkabiven, ATC B05BA10 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 40800 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tamsulosin + Solifenacin, ATC G04CA53 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||